Translation Error

The U.S. market was valued at USD 2.07 billion in 2023 and USD 2.13 billion in 2024, with an expected CAGR of 18% from 2025 to 2034.

The hospitals segment led the market with a revenue share of 60.2% in 2024.

The global hypodermic syringes and needles industry was valued at USD 7.3 billion in 2024 and is projected to grow at a CAGR of 2.9% from 2025 to 2034, reaching USD 9.8 billion by 2034.

وتشمل الجهات الفاعلة الرئيسية في السوق آبوت، وب. براون، وBD (Becton, Dickinson and Company), Cardinal Health, Catalent, Connecticut Hypodermics, DeRoyal, EXEl, HI-TECH MEDICS, ICU Medical, Lifelong MEDITECH, and McKESSON.